Vasopressin and corticotrophin-releasing hormone (CRH) both play a synergistic role in stimulating the release of adrenocorticotropic hormone (ACTH) [90], so vasopressin could possibly enhance the CRH effect during the first days of nasal obstruction-induced oral breathing. The gene discussed is CRH; the disease is Nasal congestion.